Cabot Corporation $CBT Shares Bought by Pacer Advisors Inc.

Posted by Geri Gentry on Aug 5th, 2026

Pacer Advisors Inc. increased its stake in shares of Cabot Corporation (NYSE:CBT – Free Report) by 8.1% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 247,790 shares of the specialty chemicals company’s stock after purchasing an additional 18,538 shares during the period. Pacer Advisors Inc.’s holdings in Cabot were worth $18,661,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Amundi purchased a new stake in Cabot during the 1st quarter worth approximately $275,000. California State Teachers Retirement System raised its holdings in shares of Cabot by 25.4% during the first quarter. California State Teachers Retirement System now owns 63,369 shares of the specialty chemicals company’s stock valued at $4,772,000 after acquiring an additional 12,850 shares during the last quarter. Empowered Funds LLC lifted its position in shares of Cabot by 14.9% in the first quarter. Empowered Funds LLC now owns 39,441 shares of the specialty chemicals company’s stock valued at $2,970,000 after acquiring an additional 5,107 shares in the last quarter. Quantinno Capital Management LP lifted its holdings in Cabot by 33.7% in the 1st quarter. Quantinno Capital Management LP now owns 21,278 shares of the specialty chemicals company’s stock valued at $1,603,000 after purchasing an additional 5,362 shares in the last quarter. Finally, Lazard Asset Management LLC grew its holdings in shares of Cabot by 96.2% during the first quarter. Lazard Asset Management LLC now owns 43,219 shares of the specialty chemicals company’s stock worth $3,255,000 after buying an additional 21,194 shares in the last quarter. 93.18% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on CBT shares. JPMorgan Chase & Co. raised their price target on shares of Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. UBS Group upped their price objective on shares of Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a research note on Friday, May 8th. Truist Financial started coverage on shares of Cabot in a report on Monday, June 8th. They issued a “buy” rating and a $98.00 price objective for the company. Mizuho raised their target price on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, June 25th. Finally, Wall Street Zen cut Cabot from a “buy” rating to a “hold” rating in a report on Saturday. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Cabot currently has a consensus rating of “Hold” and a consensus target price of $85.80.

Read Our Latest Research Report on CBT

Cabot Stock Down 9.0%

Shares of CBT opened at $81.51 on Wednesday. Cabot Corporation has a 52-week low of $58.33 and a 52-week high of $94.53. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51. The stock has a fifty day simple moving average of $87.96 and a two-hundred day simple moving average of $79.62. The company has a market capitalization of $4.21 billion, a PE ratio of 15.41, a price-to-earnings-growth ratio of 11.63 and a beta of 0.84.

Cabot (NYSE:CBT – Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating the consensus estimate of $1.66 by $0.01. Cabot had a net margin of 5.23% and a return on equity of 20.37%. The firm had revenue of $982.00 million for the quarter, compared to analysts’ expectations of $943.16 million. During the same quarter in the previous year, the company posted $1.90 EPS. The company’s revenue was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, equities analysts forecast that Cabot Corporation will post 6.37 EPS for the current year.

Cabot Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be issued a $0.4725 dividend. This represents a $1.89 annualized dividend and a yield of 2.3%. The ex-dividend date is Friday, August 28th. Cabot’s payout ratio is presently 35.73%.

Cabot News Roundup

Here are the key news stories impacting Cabot this week:

Positive Sentiment: Adjusted EPS was $1.67, narrowly exceeding the $1.66 consensus estimate, while revenue increased 6.4% year over year to $982 million, well above expectations of $943.2 million. Cabot Tops Q3 Earnings and Revenue Estimates
Positive Sentiment: Reinforcement Materials and Performance Chemicals generated segment EBIT of $97 million and $68 million, respectively. Cabot also reaffirmed its expectation of approximately $40 million in fiscal 2026 EBITDA from Battery Materials while expanding conductive-additive capacity in the United States and China. Cabot Corporation Reports Third Quarter Fiscal Year 2026 Results
Neutral Sentiment: Management tightened fiscal 2026 adjusted EPS guidance to $6.15-$6.45, broadly surrounding the $6.32 analyst consensus. The earnings call provided additional discussion of operating conditions, segment performance and the company’s outlook. Cabot Q3 2026 Earnings Call Transcript
Negative Sentiment: GAAP results were substantially weaker: net income attributable to Cabot fell to $6 million, or $0.12 per diluted share, from $101 million, or $1.86 per share, a year earlier. Adjusted EPS also declined from $1.90, reflecting a difficult comparison and $1.55 per-share impact from certain items. Cabot Reports Fiscal Q3 Net Income
Negative Sentiment: An analyst downgraded Cabot, citing more limited upside potential and concerns extending into fiscal 2027-2028. The planned October 1 CEO transition from Sean Keohane to Erica McLaughlin adds another near-term uncertainty for investors. Cabot Successful Returns Downgrade

About Cabot

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.